Siemens has achieved a significant milestone by obtaining UL listing for a 120-volt, single pole solid-state circuit breaker, making it the first company to do so. This innovative device enhances safety and reliability through its semiconductor-based design that allows for faster current interruption and operates with passive heat management. It is suitable for residential, commercial, and light industrial applications and is made of fully recyclable materials, supporting Siemens’ sustainability goals. The launch signifies a leap towards digital power management.
Ohio State Wexner Medical Center and Siemens Healthineers have formed a strategic partnership to enhance patient care and research through advanced imaging and treatment technologies. This five-year alliance will improve access to personalized medical solutions, particularly for obese and claustrophobic patients. Key initiatives include advanced radiation oncology and vascular robotics, with the scheduled opening of an outpatient center in 2023. The collaboration aims to foster breakthroughs in individualized healthcare, leveraging AI and big data for improved patient outcomes.
SHL Telemedicine has appointed Jason Bottiglieri as General Manager of its US subsidiary as of June 23, 2022. Bottiglieri brings over 25 years of experience in the cardiovascular device market, having held leadership roles at companies like Invatec, Spectranetics, and Infraredx. His expertise is expected to drive the growth of SHL's SmartHeart™ technology in the US market. SHL aims to leverage Bottiglieri's background to enhance the commercialization of its innovative telemedicine solutions, further strengthening its foothold in the healthcare sector.
Summary not available.
Siemens announced a $54 million investment to enhance its manufacturing capabilities in Texas and California, focusing on electrical equipment for critical infrastructure like EV charging and data centers. The expansion includes a $10 million upgrade in Grand Prairie, Texas, and over $40 million for a new facility in Pomona, California. This initiative aims to create nearly 300 jobs and supports Siemens' goal to produce over 1 million EV chargers in the U.S. in the next four years, showcasing Siemens' commitment to American infrastructure development.
Siemens has introduced a new sustainable EV charging concept, the VersiCharge XL, designed for rapid installation and scalability. This industry-first solution significantly enhances EV infrastructure by leveraging modular design with low carbon materials from Nexii. The charging structure minimizes disruption to existing parking lots and is suitable for diverse environments. Siemens aims to produce 1 million EV chargers by 2025, contributing to the national EV network and supporting community climate goals, with $20 million funding allocated for Georgia this year.
Siemens eMobility announced the Ford Charge Station Pro, an innovative electric vehicle charger for the Ford F-150 Lightning, has received certification under the expanded UL 9741 standard. This charger, with a peak power of 19.2kW, is the first bidirectional-ready EV solution available at retail scale. The station enables Ford Intelligent Backup Power, allowing the F-150 Lightning to act as a power source during outages. Future firmware updates will enhance interaction with the grid, promoting sustainable and reliable home charging.
Siemens Healthineers announced the availability of the CLINITEST Rapid COVID-19 Antigen Self-Test in the U.S. after receiving FDA Emergency Use Authorization. The test provides accurate results in just 15 minutes and can be self-administered by individuals aged 14 and older. The company is supplying millions of tests to the U.S. federal government and various organizations, aiming to enhance COVID-19 testing accessibility during ongoing surges. The tests are also available for purchase online and in stores, including Amazon.com.
Siemens Healthineers has received FDA Emergency Use Authorization (EUA) for its CLINITEST Rapid COVID-19 Antigen Self-Test, allowing unsupervised self-testing for individuals aged 14 and over. The test provides results in just 15 minutes and is part of a nationwide retail distribution to meet increasing COVID-19 testing demands. The test has shown an accuracy with sensitivity at 86.5% and specificity at 99.3%, ensuring reliable results for users. The product is set to launch in January 2022, with production capabilities in the tens of millions per month.
Siemens Healthineers' ELF Test has been recognized as the top-performing biomarker in the NIMBLE study, as reported in a presentation at The Liver Meeting 2021. The ELF Test excelled in identifying fibrosis stages ≥2, with enhanced performance for stages ≥3 and 4. This recognition supports its potential to transform NASH clinical trials by reducing reliance on invasive liver biopsies. The NIMBLE project aims to validate non-invasive biomarkers for diagnosing NASH, impacting about 15 million people in the U.S. Successful regulatory qualification could revolutionize clinical trial methodologies.